<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="48b021e4-5897-42fd-12be-3190a9b087e8"><labelDrug name="ATACAND HCT"><Normalization><mmtx cui="C0939259" preferredWord="Atacand HCT" semType="phsu"/></Normalization></labelDrug><generic name="Candesartan cilexetil and Hydrochlorothiazide"/><sentence id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.1" text="ATACAND HCT (candesartan cilexetil and hydrochlorothiazide) tablet" type="negative"><entity charOffset="0:11" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.1.e.0" text="atacand hct" type="Biomedical_Entity"><Normalization><mmtx cui="C0939259" phraseText="ATACAND HCT (candesartan cilexetil" preferredWord="Atacand HCT" semType="phsu"/><RxNorm RxCui="215458"/></Normalization></entity><entity charOffset="39:58" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.1.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="13:34" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.1.e.2" text="candesartan cilexetil" type="Biomedical_Entity"><Normalization><mmtx cui="C0527379" phraseText="ATACAND HCT (candesartan cilexetil" preferredWord="candesartan cilexetil" semType="phsu, orch"/><RxNorm RxCui="214354"/></Normalization></entity><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.1.e.0" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.1.e.1"/><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.1.e.0" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.1.e.2"/><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.1.e.2" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.1.e.1"/></sentence><sentence id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.2" text="ATACAND HCT (candesartan cilexetil hydrochlorothiazide) tablet" type="negative"><entity charOffset="0:11" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.2.e.0" text="atacand hct" type="Biomedical_Entity"><Normalization><mmtx cui="C0939259" phraseText="ATACAND HCT (candesartan cilexetil hydrochlorothiazide" preferredWord="Atacand HCT" semType="phsu"/><RxNorm RxCui="215458"/></Normalization></entity><entity charOffset="13:54" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.2.e.1" text="candesartan cilexetil hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C1302038" phraseText="ATACAND HCT (candesartan cilexetil hydrochlorothiazide" preferredWord="Candesartan cilexetil + hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="214354"/></Normalization></entity><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.2.e.0" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.2.e.1"/></sentence><sentence id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.3" text="ATACAND HCT (candesartan cilexetil-hydrochlorothiazide) combines an angiotensin II receptor (type AT1) antagonist and a diuretic, hydrochlorothiazide." type="negative"><entity charOffset="120:128" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.3.e.0" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="a diuretic, hydrochlorothiazide." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="13:54" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.3.e.1" text="candesartan cilexetil-hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C1302038" phraseText="ATACAND HCT (candesartan cilexetil-hydrochlorothiazide" preferredWord="Candesartan cilexetil + hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="214354"/></Normalization></entity><entity charOffset="68:82" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.3.e.2" text="angiotensin ii" type="Biomedical_Entity"><Normalization><mmtx cui="C0003009" phraseText="an angiotensin II receptor" preferredWord="Angiotensin II" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="0:11" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.3.e.3" text="atacand hct" type="Biomedical_Entity"><Normalization><mmtx cui="C0939259" phraseText="ATACAND HCT (candesartan cilexetil-hydrochlorothiazide" preferredWord="Atacand HCT" semType="phsu"/><RxNorm RxCui="215458"/></Normalization></entity><entity charOffset="130:149" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.3.e.4" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="a diuretic, hydrochlorothiazide." preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.3.e.1" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.3.e.0"/><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.3.e.2" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.3.e.0"/><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.3.e.3" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.3.e.0"/><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.3.e.0" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.3.e.4"/><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.3.e.1" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.3.e.2"/><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.3.e.3" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.3.e.1"/><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.3.e.1" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.3.e.4"/><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.3.e.3" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.3.e.2"/><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.3.e.2" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.3.e.4"/><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.3.e.3" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.3.e.4"/></sentence><sentence id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.9" text="ATACAND HCT is contraindicated in patients who are hypersensitive to candesartan, to hydrochlorothiazide or to other sulfonamide-derived drugs." type="negative"><entity charOffset="117:128" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.9.e.0" text="sulfonamide" type="Biomedical_Entity"><Normalization><mmtx cui="C0599503" phraseText="or to other sulfonamide-derived drugs." preferredWord="Sulfonamide Anti-Infective Agents" semType="orch, antb"/><RxNorm RxCui="1427600"/></Normalization></entity><entity charOffset="69:80" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.9.e.1" text="candesartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0717550" phraseText="hypersensitive to candesartan," preferredWord="candesartan" semType="phsu, orch"/><RxNorm RxCui="214354"/></Normalization></entity><entity charOffset="0:11" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.9.e.2" text="atacand hct" type="Biomedical_Entity"><Normalization><mmtx cui="C0939259" phraseText="ATACAND HCT" preferredWord="Atacand HCT" semType="phsu"/><RxNorm RxCui="215458"/></Normalization></entity><entity charOffset="85:104" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.9.e.3" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="to hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.9.e.1" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.9.e.0"/><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.9.e.2" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.9.e.0"/><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.9.e.3" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.9.e.0"/><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.9.e.2" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.9.e.1"/><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.9.e.1" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.9.e.3"/><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.9.e.2" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.9.e.3"/></sentence><sentence biomedicalEntities="2" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.10" lineNumber="15" text="Do not co-administer aliskiren with ATACAND HCT in patients with diabetes (see PRECAUTIONS, Drug Interactions)." type="regular"><entity charOffset="0:20" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.10.e.0" text="Do not co-administer" type="Caution_Interaction"/><entity charOffset="21:30" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.10.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with ATACAND HCT" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="36:47" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.10.e.3" text="ATACAND HCT" type="Drug"><Normalization><mmtx cui="C0939259" phraseText="aliskiren with ATACAND HCT" preferredWord="Atacand HCT" semType="phsu"/><RxNorm RxCui="215458"/></Normalization></entity><entity charOffset="65:73" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.10.e.4" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes" preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes" preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.10.ddi.1"><interaction trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.10.e.0"><relations><relation type="hasContext"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.10.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.10.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.10.e.2"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.10.e.4" ddi="true" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.10.e.2" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.10.e.3" trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.10.e.0" type="Caution_Interaction"/></sentence><sentence id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.20" text="Most epidemiologic studies examining fetal abnormalities after exposure to antihypertensive use in the first trimester have not distinguished drugs affecting the renin-angiotensin system from other antihypertensive agents. " type="negative"><entity charOffset="168:179" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.20.e.0" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="the renin-angiotensin system from other antihypertensive agents." preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="198:221" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.20.e.1" text="antihypertensive agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="the renin-angiotensin system from other antihypertensive agents." preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="75:91" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.20.e.2" text="antihypertensive" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="to antihypertensive use" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.20.e.0" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.20.e.1"/><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.20.e.2" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.20.e.0"/></sentence><sentence id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.29" text="There was no evidence of teratogenicity or other adverse effects on embryo-fetal development when pregnant mice, rats or rabbits were treated orally with candesartan cilexetil alone or in combination with hydrochlorothiazide. " type="negative"><entity charOffset="205:224" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.29.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="with hydrochlorothiazide." preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="154:175" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.29.e.1" text="candesartan cilexetil" type="Biomedical_Entity"><Normalization><mmtx cui="C0527379" phraseText="orally with candesartan cilexetil" preferredWord="candesartan cilexetil" semType="phsu, orch"/><RxNorm RxCui="214354"/></Normalization></entity><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.29.e.1" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.29.e.0"/></sentence><sentence id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.44" text="they should be followed closely for the first 2 weeks of treatment and whenever the dose of candesartan or diuretic is increased." type="negative"><entity charOffset="92:103" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.44.e.0" text="candesartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0717550" phraseText="the dose of candesartan" preferredWord="candesartan" semType="phsu, orch"/><RxNorm RxCui="214354"/></Normalization></entity><entity charOffset="107:115" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.44.e.1" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.44.e.0" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.44.e.1"/></sentence><sentence id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.47" text="Changes in renal function including acute renal failure can be caused by drugs that inhibit the renin-angiotensin system and by diuretics. " type="negative"><entity charOffset="128:137" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.47.e.0" text="diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="and by diuretics." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="102:113" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.47.e.1" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="the renin-angiotensin system" preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.47.e.1" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.47.e.0"/></sentence><sentence id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.48" text="Patients whose renal function may depend in part on the activity of the renin-angiotensin system (e.g., patients with renal artery stenosis, chronic kidney disease, severe heart failure, or volume depletion) may be at particular risk of developing oliguria, progressive azotemia, or acute renal failure on ATACAND HCT. " type="negative"><entity charOffset="78:89" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.48.e.0" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="of the renin-angiotensin system" preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="306:317" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.48.e.1" text="atacand hct" type="Biomedical_Entity"><Normalization><mmtx cui="C0939259" phraseText="acute renal failure on ATACAND HCT." preferredWord="Atacand HCT" semType="phsu"/><RxNorm RxCui="215458"/></Normalization></entity><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.48.e.0" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.48.e.1"/></sentence><sentence id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.55" text="In clinical trials of various doses of candesartan cilexetil and hydrochlorothiazide, the incidence of hypertensive patients who developed hypokalemia (serum potassium &lt;3.5 mEq/L) was 2.5% versus 2.1% for placebo; " type="negative"><entity charOffset="65:84" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.55.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="158:167" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.55.e.1" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="(serum potassium" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="39:60" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.55.e.2" text="candesartan cilexetil" type="Biomedical_Entity"><Normalization><mmtx cui="C0527379" phraseText="of candesartan cilexetil" preferredWord="candesartan cilexetil" semType="phsu, orch"/><RxNorm RxCui="214354"/></Normalization></entity><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.55.e.0" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.55.e.1"/><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.55.e.2" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.55.e.0"/><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.55.e.2" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.55.e.1"/></sentence><sentence id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.57" text="No patient receiving ATACAND HCT 16-12.5 mg or 32-12.5 mg was discontinued due to increases or decreases in serum potassium." type="negative"><entity charOffset="114:123" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.57.e.0" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="decreases in serum potassium." preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="21:32" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.57.e.1" text="atacand hct" type="Biomedical_Entity"><Normalization><mmtx cui="C0939259" phraseText="No patient receiving ATACAND HCT 16-12.5 mg" preferredWord="Atacand HCT" semType="phsu"/><RxNorm RxCui="215458"/></Normalization></entity><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.57.e.1" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.57.e.0"/></sentence><sentence id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.59" text="Hydrochlorothiazide, a sulfonamide, can cause an idiosyncratic reaction, resulting in acute transient myopia and acute angle-closure glaucoma. " type="negative"><entity charOffset="23:34" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.59.e.0" text="sulfonamide" type="Biomedical_Entity"><Normalization><mmtx cui="C0599503" phraseText="a sulfonamide," preferredWord="Sulfonamide Anti-Infective Agents" semType="orch, antb"/><RxNorm RxCui="1427600"/></Normalization></entity><entity charOffset="0:19" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.59.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Hydrochlorothiazide," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.59.e.1" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.59.e.0"/></sentence><sentence id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.69" text="Hydrochlorothiazide may alter glucose tolerance and raise serum levels of cholesterol and triglycerides." type="negative"><entity charOffset="0:19" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.69.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="30:37" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.69.e.1" text="glucose" type="Biomedical_Entity"><Normalization><mmtx cui="C0017725" phraseText="glucose tolerance" preferredWord="Glucose" semType="bacs, phsu, carb"/><RxNorm RxCui="4850"/></Normalization></entity><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.69.e.0" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.69.e.1"/></sentence><sentence id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.71" text="Thiazides decrease urinary calcium excretion and may cause mild elevation of serum calcium. " type="negative"><entity charOffset="83:90" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.71.e.0" text="calcium" type="Biomedical_Entity"><Normalization><mmtx cui="C2936886" phraseText="mild elevation of serum calcium." preferredWord="Calcium [EPC]" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.71.e.1" text="thiazides" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="Thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="27:34" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.71.e.2" text="calcium" type="Biomedical_Entity"><Normalization><mmtx cui="C2936886" phraseText="urinary calcium excretion" preferredWord="Calcium [EPC]" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.71.e.1" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.71.e.0"/><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.71.e.1" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.71.e.2"/></sentence><sentence biomedicalEntities="3" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.85" lineNumber="85" text="Tell patients receiving ATACAND HCT not to use potassium supplements or salt substitutes containing potassium without consulting the prescribing physician." type="regular"><entity charOffset="24:35" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.85.e.0" text="ATACAND HCT" type="Drug"><Normalization><mmtx cui="C0939259" phraseText="ATACAND HCT" preferredWord="Atacand HCT" semType="phsu"/><RxNorm RxCui="215458"/></Normalization></entity><entity charOffset="47:68" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.85.e.1" text="potassium supplements" type="Drug_Class"><Normalization><mmtx cui="C0304475" phraseText="potassium supplements" preferredWord="Potassium supplement" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="72:109" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.85.e.2" text="salt substitutes containing potassium" type="Substance"><Normalization><mmtx cui="C0784217" phraseText="salt substitutes" preferredWord="Salt Substitute" semType="inch, phsu"/><mmtx cui="C0597277" phraseText="potassium without consulting" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="9547"/></Normalization></entity><entity charOffset="36:46" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.85.e.3" text="not to use" type="Caution_Interaction"/><drugInteraction id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.85.ddi.1"><interaction trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.85.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.85.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.85.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.85.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.85.e.0" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.85.e.1" trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.85.e.3" type="Caution_Interaction"/><pair ddi="true" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.85.e.0" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.85.e.2" trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.85.e.3" type="Caution_Interaction"/><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.85.e.1" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.85.e.2"/></sentence><sentence biomedicalEntities="4" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.89" lineNumber="93" text="Non-Steroidal Anti-Inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors) In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, co-administration of NSAIDs, including selective COX-2 inhibitors, with angiotensin II receptor antagonists, including candesartan, may result in deterioration of renal function, including possible acute renal failure. " type="regular"><entity charOffset="247:253" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.89.e.0" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="co-administration of NSAIDs," preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="265:291" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.89.e.1" text="selective COX-2 inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1257954" phraseText="selective COX-2 inhibitors," preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="298:333" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.89.e.3" text="angiotensin II receptor antagonists" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="with angiotensin II receptor antagonists," preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="345:356" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.89.e.4" text="candesartan" type="Drug"><Normalization><mmtx cui="C0717550" phraseText="candesartan," preferredWord="candesartan" semType="phsu, orch"/><RxNorm RxCui="214354"/></Normalization></entity><entity charOffset="372:403" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.89.e.6" text="deterioration of renal function" type="Specific_Interaction"/><entity charOffset="424:443" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.89.e.8" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="possible acute renal failure." preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><entity charOffset="126:133" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.89.e.10" text="elderly" type="SPAN"/><entity charOffset="135:150" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.89.e.11" text="volume-depleted" type="SPAN"/><entity charOffset="198:224" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.89.e.12" text="compromised renal function" type="SPAN"/><classClassMembership drugClass="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.89.e.1"/><drugClassMembership drug="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.89.e.4" drugClass="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.89.e.3"/><drugInteraction id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.89.ddi.1"><interaction trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.89.e.6"><relations><relation type="hasContext"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.89.e.12"/></relation><relation type="hasObject"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.89.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.89.e.0"/></relation><relation type="hasContext"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.89.e.10"/></relation><relation type="hasContext"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.89.e.11"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.89.ddi.2"><interaction trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.89.e.8"><relations><relation type="hasContext"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.89.e.12"/></relation><relation type="hasObject"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.89.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.89.e.0"/></relation><relation type="hasContext"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.89.e.10"/></relation><relation type="hasContext"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.89.e.11"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.89.e.12, Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.89.e.10, Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.89.e.11" ddi="true" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.89.e.0" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.89.e.3" trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.89.e.6" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.91" lineNumber="93" text="Monitor renal function periodically in patients receiving candesartan and NSAID therapy." type="regular"><entity charOffset="0:7" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.91.e.0" text="Monitor" type="Caution_Interaction"/><entity charOffset="58:69" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.91.e.2" text="candesartan" type="Drug"><Normalization><mmtx cui="C0717550" phraseText="candesartan" preferredWord="candesartan" semType="phsu, orch"/><RxNorm RxCui="214354"/></Normalization></entity><entity charOffset="74:79" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.91.e.3" text="NSAID" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="NSAID therapy." preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><drugInteraction id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.91.ddi.1"><interaction trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.91.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.91.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.91.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.91.e.2" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.91.e.3" trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.91.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.92" lineNumber="95" text="The antihypertensive effect of angiotensin II receptor antagonists, including candesartan may be attenuated by NSAIDs including selective COX-2 inhibitors." type="regular"><entity charOffset="31:66" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.92.e.0" text="angiotensin II receptor antagonists" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="The antihypertensive effect of angiotensin II receptor antagonists," preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="78:89" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.92.e.1" text="candesartan" type="Drug"><Normalization><mmtx cui="C0717550" phraseText="candesartan" preferredWord="candesartan" semType="phsu, orch"/><RxNorm RxCui="214354"/></Normalization></entity><entity charOffset="111:117" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.92.e.3" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="attenuated by NSAIDs" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="128:154" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.92.e.4" text="selective COX-2 inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1257954" phraseText="selective COX-2 inhibitors." preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="4:27|90:107" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.92.e.6" text="antihypertensive effect may be attenuated" type="Specific_Interaction"/><drugClassMembership drug="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.92.e.1" drugClass="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.92.e.0"/><classClassMembership drugClass="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.92.e.4"/><drugInteraction id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.92.ddi.1"><interaction trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.92.e.6"><relations><relation type="hasObject"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.92.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.92.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.92.e.0" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.92.e.3" trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.92.e.6" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.93" lineNumber="97" text="Lithium   Renal clearance of lithium is reduced by thiazides and increases the risk of lithium toxicity. " type="regular"><entity charOffset="10:25|37:47" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.93.e.0" text="Renal clearance is reduced" type="Increase_Interaction"/><entity charOffset="51:60" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.93.e.2" text="thiazides" type="Drug_Class"><Normalization><mmtx cui="C0541746" phraseText="reduced by thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="95:103" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.93.e.3" text="toxicity" type="Increase_Interaction"/><entity charOffset="29:36" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.93.e.5" text="lithium" type="Drug"><Normalization><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="87:94" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.93.e.6" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="the risk of lithium toxicity." preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.93.ddi.1"><interaction trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.93.e.0"><relations><relation type="hasObject"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.93.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.93.e.2"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.93.ddi.2"><interaction trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.93.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.93.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.93.e.6"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.93.e.5" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.93.e.2" trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.93.e.0" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.93.e.2" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.93.e.6" trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.93.e.3" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.94" lineNumber="97" text="Reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with ACE inhibitors, and with some angiotensin II receptor antagonists. " type="regular"><entity charOffset="122:129" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.94.e.0" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="reported during concomitant administration of lithium" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="135:149" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.94.e.1" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="with ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="165:200" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.94.e.2" text="angiotensin II receptor antagonists" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="and with some angiotensin II receptor antagonists." preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="11:29|38:52" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.94.e.3" text="increases in serum concentrations" type="Increase_Interaction"/><entity charOffset="57:65" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.94.e.5" text="toxicity" type="Increase_Interaction"/><entity charOffset="30:37" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.94.e.7" text="lithium" type="Drug"><Normalization><mmtx cui="C1441405" phraseText="Reversible increases in serum lithium concentrations" preferredWord="Lithium.serum" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.94.ddi.1"><interaction trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.94.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.94.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.94.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.94.e.7"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.94.ddi.2"><interaction trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.94.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.94.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.94.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.94.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.94.e.7" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.94.e.2" trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.94.e.3" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.94.e.7" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.94.e.1" trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.94.e.3" type="Increase_Interaction"/><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.94.e.1" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.94.e.2"/><pair ddi="true" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.94.e.0" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.94.e.2" trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.94.e.5" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.94.e.0" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.94.e.1" trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.94.e.5" type="Increase_Interaction"/><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.94.e.1" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.94.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.95" lineNumber="97" text="An increase in serum lithium concentration has been reported during concomitant administration of lithium with candesartan cilexetil. " type="regular"><entity charOffset="3:20|29:42" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.95.e.0" text="increase in serum concentration" type="Increase_Interaction"/><entity charOffset="21:28" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.95.e.2" text="lithium" type="Drug"><Normalization><mmtx cui="C1441405" phraseText="An increase in serum lithium concentration" preferredWord="Lithium.serum" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="111:132" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.95.e.3" text="candesartan cilexetil" type="Drug"><Normalization><mmtx cui="C0527379" phraseText="with candesartan cilexetil." preferredWord="candesartan cilexetil" semType="phsu, orch"/><RxNorm RxCui="214354"/></Normalization></entity><drugInteraction id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.95.ddi.1"><interaction trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.95.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.95.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.95.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.95.e.2" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.95.e.3" trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.95.e.0" type="Increase_Interaction"/></sentence><sentence id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.98" text="Dual Blockade of the Renin-Angiotensin System (RAS)" type="negative"><entity charOffset="5:13" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.98.e.0" text="blockade" type="Biomedical_Entity"><Normalization><mmtx cui="C3540676" phraseText="Dual Blockade of the Renin-Angiotensin System" preferredWord="Blockade" semType="phsu"/><RxNorm RxCui="1423936"/></Normalization></entity><entity charOffset="27:38" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.98.e.1" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="Dual Blockade of the Renin-Angiotensin System" preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.98.e.0" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.98.e.1"/></sentence><sentence biomedicalEntities="3" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99" lineNumber="103" text="Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy. " type="irregular"><entity charOffset="30:59" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99.e.0" text="angiotensin receptor blockers" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="with angiotensin receptor blockers," preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><mmtx cui="C0815017" phraseText="with angiotensin receptor blockers," preferredWord="Angiotensin Receptor Antagonists" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="61:75" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99.e.1" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="80:89" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="128:139" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99.e.3" text="hypotension" type="Specific_Interaction"/><entity charOffset="141:153" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99.e.5" text="hyperkalemia" type="Specific_Interaction"/><entity charOffset="159:184" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99.e.7" text="changes in renal function" type="Specific_Interaction"/><entity charOffset="196:215" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99.e.9" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="acute renal failure" preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99.ddi.1"><interaction trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.97" text="Interactions with Candesartan Cilexetil"><entity charOffset="18:39" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.97.e.0" text="Candesartan Cilexetil" type="Drug"><Normalization><mmtx cui="C0527379" phraseText="Interactions with Candesartan Cilexetil" preferredWord="candesartan cilexetil" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.98" text="Dual Blockade of the Renin-Angiotensin System (RAS)"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99.ddi.2"><interaction trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.97" text="Interactions with Candesartan Cilexetil"><entity charOffset="18:39" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.97.e.0" text="Candesartan Cilexetil" type="Drug"><Normalization><mmtx cui="C0527379" phraseText="Interactions with Candesartan Cilexetil" preferredWord="candesartan cilexetil" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.98" text="Dual Blockade of the Renin-Angiotensin System (RAS)"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99.ddi.3"><interaction trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99.e.7"><relations><relation type="hasPrecipitant"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.97" text="Interactions with Candesartan Cilexetil"><entity charOffset="18:39" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.97.e.0" text="Candesartan Cilexetil" type="Drug"><Normalization><mmtx cui="C0527379" phraseText="Interactions with Candesartan Cilexetil" preferredWord="candesartan cilexetil" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.98" text="Dual Blockade of the Renin-Angiotensin System (RAS)"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99.ddi.4"><interaction trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99.e.9"><relations><relation type="hasPrecipitant"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.97" text="Interactions with Candesartan Cilexetil"><entity charOffset="18:39" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.97.e.0" text="Candesartan Cilexetil" type="Drug"><Normalization><mmtx cui="C0527379" phraseText="Interactions with Candesartan Cilexetil" preferredWord="candesartan cilexetil" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.98" text="Dual Blockade of the Renin-Angiotensin System (RAS)"/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99.e.1" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99.e.2"/><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99.e.0" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99.e.1"/><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99.e.0" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99.e.1"/><pair ddi="true" e1="labelDrug" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.99.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.100" lineNumber="103" text="Closely monitor blood pressure, renal function and electrolytes in patients on ATACAND HCT and other agents that affect the RAS." type="regular"><entity charOffset="8:15" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.100.e.0" text="monitor" type="Caution_Interaction"/><entity charOffset="79:90" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.100.e.2" text="ATACAND HCT" type="Drug"><Normalization><mmtx cui="C0939259" phraseText="on ATACAND HCT" preferredWord="Atacand HCT" semType="phsu"/><RxNorm RxCui="215458"/></Normalization></entity><entity charOffset="101:127" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.100.e.3" text="agents that affect the RAS" type="Drug_Class"><Normalization><mmtx cui="C1254351" phraseText="other agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="126263"/></Normalization></entity><drugInteraction id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.100.ddi.1"><interaction trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.100.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.100.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.100.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.100.e.2" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.100.e.3" trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.100.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.101" lineNumber="105" text="Do not co-administer aliskiren with ATACAND HCT in patients with diabetes. " type="regular"><entity charOffset="21:30" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.101.e.0" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with ATACAND HCT" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="36:47" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.101.e.1" text="ATACAND HCT" type="Drug"><Normalization><mmtx cui="C0939259" phraseText="aliskiren with ATACAND HCT" preferredWord="Atacand HCT" semType="phsu"/><RxNorm RxCui="215458"/></Normalization></entity><entity charOffset="65:73" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.101.e.2" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes." preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes." preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><entity charOffset="0:20" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.101.e.3" text="Do not co-administer" type="Caution_Interaction"/><drugInteraction id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.101.ddi.1"><interaction trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.101.e.3"><relations><relation type="hasContext"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.101.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.101.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.101.e.0"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.101.e.2" ddi="true" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.101.e.0" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.101.e.1" trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.101.e.3" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.102" lineNumber="105" text="Avoid use of aliskiren with ATACAND HCT in patients with renal impairment (GFR &lt;60 ml/min) (see CONTRAINDICATIONS)." type="regular"><entity charOffset="13:22" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.102.e.0" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="use of aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="28:39" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.102.e.1" text="ATACAND HCT" type="Drug"><Normalization><mmtx cui="C0939259" phraseText="with ATACAND HCT" preferredWord="Atacand HCT" semType="phsu"/><RxNorm RxCui="215458"/></Normalization></entity><entity charOffset="57:73" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.102.e.2" text="renal impairment" type="SPAN"><Normalization><mmtx cui="C0035078" phraseText="with renal impairment" preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="with renal impairment" preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.102.e.3" text="Avoid use" type="Caution_Interaction"/><drugInteraction id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.102.ddi.1"><interaction trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.102.e.3"><relations><relation type="hasObject"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.102.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.102.e.0"/></relation><relation type="hasContext"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.102.e.2"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.102.e.2" ddi="true" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.102.e.0" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.102.e.1" trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.102.e.3" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.104" lineNumber="109" text="Alcohol, barbiturates, or narcotics   Potentiation of orthostatic hypotension may occur." type="irregular"><entity charOffset="0:7" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.104.e.0" text="Alcohol" type="Substance"><Normalization><mmtx cui="C0001975" phraseText="Alcohol," preferredWord="Alcohols" semType="phsu, orch"/><RxNorm RxCui="448"/></Normalization></entity><entity charOffset="9:21" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.104.e.1" text="barbiturates" type="Drug_Class"><Normalization><mmtx cui="C0004745" phraseText="barbiturates," preferredWord="Barbiturates" semType="phsu, orch"/><RxNorm RxCui="1437144"/></Normalization></entity><entity charOffset="26:35" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.104.e.2" text="narcotics" type="Drug_Class"><Normalization><mmtx cui="C0027415" phraseText="narcotics   Potentiation of orthostatic hypotension" preferredWord="Narcotics" semType="phsu, hops"/><RxNorm RxCui="992359"/></Normalization></entity><entity charOffset="38:77" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.104.e.3" text="Potentiation of orthostatic hypotension" type="Specific_Interaction"><Normalization><mmtx cui="C0149746" phraseText="narcotics   Potentiation of orthostatic hypotension" preferredWord="Orthostasis" semType="sosy"/></Normalization></entity><drugInteraction id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.104.ddi.1"><interaction trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.104.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.104.e.1"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.103" text="Interactions with Hydrochlorothiazide"><entity charOffset="18:37" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.103.e.0" text="Hydrochlorothiazide" type="Drug"><Normalization><mmtx cui="C0020261" phraseText="Interactions with Hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.104.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.104.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.104.e.1" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.104.e.2"/><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.104.e.0" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.104.e.1"/><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.104.e.0" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.104.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.104.e.1"/><pair ddi="true" e1="labelDrug" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.104.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.104.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.105" lineNumber="111" text="Antidiabetic drugs (oral agents and insulin)   Dosage adjustment of the antidiabetic drug may be required." type="irregular"><anaphoraRelation><anaphoraEntity charOffset="72:89" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.105.e.4" text="antidiabetic drug" type="Expression"/><antecedentEntity charOffset="36-43" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.105.e.3" text="insulin" type="Drug"/></anaphoraRelation><anaphoraRelation><anaphoraEntity charOffset="72:89" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.105.e.4" text="antidiabetic drug" type="Expression"/><antecedentEntity charOffset="0-31" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.105.e.2" text="Antidiabetic drugs oral agents" type="Drug_Class"/></anaphoraRelation><entity charOffset="47:64" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.105.e.0" text="Dosage adjustment" type="Caution_Interaction"/><entity charOffset="0:18|20:31" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.105.e.2" text="Antidiabetic drugs oral agents" type="Drug_Class"><Normalization><mmtx cui="C0935929" phraseText="Antidiabetic drugs" preferredWord="Antidiabetics" semType="phsu"/><mmtx cui="C1254351" phraseText="(oral agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="282360"/></Normalization></entity><entity charOffset="36:43" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.105.e.3" text="insulin" type="Drug"><Normalization><mmtx cui="C0021641" phraseText="insulin" preferredWord="Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1533581" phraseText="insulin" preferredWord="Recombinant Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1579433" phraseText="insulin" preferredWord="Insulin [EPC]" semType="phsu"/><RxNorm RxCui="5856"/></Normalization></entity><drugInteraction id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.105.ddi.1"><interaction trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.105.e.0"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.103" text="Interactions with Hydrochlorothiazide"><entity charOffset="18:37" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.103.e.0" text="Hydrochlorothiazide" type="Drug"><Normalization><mmtx cui="C0020261" phraseText="Interactions with Hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.104" text="Alcohol, barbiturates, or narcotics   Potentiation of orthostatic hypotension may occur."/></relation><relation type="hasObject"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.105.e.4"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="3" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.106" lineNumber="113" text="Ion Exchange resins   Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively. " type="regular"><anaphoraRelation><anaphoraEntity charOffset="121:124" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.106.e.5" text="its" type="Expression"/><antecedentEntity charOffset="90-109" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.106.e.2" text="hydrochlorothiazide" type="Drug"/></anaphoraRelation><entity charOffset="45:59" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.106.e.0" text="cholestyramine" type="Drug"><Normalization><mmtx cui="C0008402" phraseText="Ion Exchange resins   Single doses of either cholestyramine" preferredWord="Cholestyramine Resin" semType="phsu, orch"/><RxNorm RxCui="2447"/></Normalization></entity><entity charOffset="63:80" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.106.e.1" text="colestipol resins" type="Drug_Class"><Normalization><mmtx cui="C0009279" phraseText="colestipol resins" preferredWord="Colestipol" semType="phsu, orch"/><RxNorm RxCui="104485"/></Normalization></entity><entity charOffset="90:109" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.106.e.2" text="hydrochlorothiazide" type="Drug"><Normalization><mmtx cui="C0020261" phraseText="the hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="114:120|125:135" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.106.e.3" text="reduce absorption" type="Decrease_Interaction"/><drugInteraction id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.106.ddi.1"><interaction trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.106.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.106.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.106.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.106.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.106.e.0" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.106.e.5" trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.106.e.3" type="Decrease_Interaction"/><pair ddi="true" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.106.e.1" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.106.e.5" trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.106.e.3" type="Decrease_Interaction"/><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.106.e.0" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.106.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.107" lineNumber="113" text="Stagger the dosage of hydrochlorothiazide and ion exchange resins such that hydrochlorothiazide is administered at least 4 hours before or 4-6 hours after the administration of resins." type="regular"><entity charOffset="0:18" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.107.e.0" text="Stagger the dosage" type="Caution_Interaction"/><entity charOffset="22:41" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.107.e.2" text="hydrochlorothiazide" type="Drug"><Normalization><mmtx cui="C0020261" phraseText="the dosage of hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="46:65" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.107.e.3" text="ion exchange resins" type="Drug_Class"><Normalization><mmtx cui="C0022014" phraseText="ion exchange resins" preferredWord="Ion Exchange Resins" semType="phsu, irda, bodm"/><RxNorm RxCui="1239134"/></Normalization></entity><drugInteraction id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.107.ddi.1"><interaction trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.107.e.0"><relations><relation type="hasObject"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.107.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.107.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.107.e.2" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.107.e.3" trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.107.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.108" lineNumber="115" text="Skeletal muscle relaxants, nondepolarizing (eg, tubocurarine)  Possible increased responsiveness to muscle relaxants such as curare derivatives." type="irregular"><entity charOffset="0:42" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.108.e.0" text="Skeletal muscle relaxants, nondepolarizing" type="Drug_Class"><Normalization><mmtx cui="C0037250" phraseText="Skeletal muscle relaxants," preferredWord="skeletal muscle relaxants" semType="phsu"/><RxNorm RxCui="1427638"/></Normalization></entity><entity charOffset="48:60" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.108.e.1" text="tubocurarine" type="Drug"><Normalization><mmtx cui="C0041345" phraseText="tubocurarine" preferredWord="Tubocurarine" semType="phsu, orch"/><RxNorm RxCui="82115"/></Normalization></entity><entity charOffset="100:116" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.108.e.3" text="muscle relaxants" type="Drug_Class"><Normalization><mmtx cui="C0358430" phraseText="Possible increased responsiveness to muscle relaxants" preferredWord="Muscle relaxants" semType="phsu"/><RxNorm RxCui="1023025"/></Normalization></entity><entity charOffset="125:143" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.108.e.4" text="curare derivatives" type="Drug_Class"><Normalization><mmtx cui="C0010463" phraseText="such as curare derivatives." preferredWord="Curare" semType="phsu, orch, hops"/><RxNorm RxCui="2953"/></Normalization></entity><entity charOffset="72:96" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.108.e.6" text="increased responsiveness" type="Increase_Interaction"/><drugClassMembership drug="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.108.e.1" drugClass="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.108.e.0"/><classClassMembership drugClass="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.108.e.4"/><drugInteraction id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.108.ddi.1"><interaction trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.108.e.6"><relations><relation type="hasObject"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.108.e.3"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.107" text="Stagger the dosage of hydrochlorothiazide and ion exchange resins such that hydrochlorothiazide is administered at least 4 hours before or 4-6 hours after the administration of resins."><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.107.e.2"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.109" lineNumber="117" text="Digitalis: Thiazide-induced hypokalemia or hypomagnesemia may predispose to digoxin toxicity." type="regular"><entity charOffset="76:83" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.109.e.0" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="predispose to digoxin toxicity." preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="84:92" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.109.e.1" text="toxicity" type="Increase_Interaction"/><entity charOffset="11:19" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.109.e.3" text="Thiazide" type="Drug_Class"><Normalization><mmtx cui="C0541746" phraseText="Thiazide-induced hypokalemia" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><drugInteraction id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.109.ddi.1"><interaction trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.109.e.1"><relations><relation type="hasObject"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.109.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.109.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.109.e.3" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.109.e.0" trigger="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.109.e.1" type="Increase_Interaction"/></sentence><sentence id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.120" text="Dose Titration by Clinical Effect: A patient whose blood pressure is not controlled on 25 mg of hydrochlorothiazide once daily can expect an incremental effect from ATACAND HCT 16-12.5 mg. " type="negative"><entity charOffset="165:176" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.120.e.0" text="atacand hct" type="Biomedical_Entity"><Normalization><mmtx cui="C0939259" phraseText="an incremental effect from ATACAND HCT 16-12.5 mg." preferredWord="Atacand HCT" semType="phsu"/><RxNorm RxCui="215458"/></Normalization></entity><entity charOffset="87:115" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.120.e.1" text="25 mg hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0986526" phraseText="controlled on 25 mg of hydrochlorothiazide" preferredWord="Hydrochlorothiazide 25 MG" semType="clnd"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="138:184" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.120.e.2" text="an 5" type="Biomedical_Entity"><Normalization><mmtx cui="C0526789" phraseText="an incremental effect from ATACAND HCT 16-12.5 mg." preferredWord="AN(5)" semType="phsu, orch"/><RxNorm RxCui="707263"/></Normalization></entity><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.120.e.1" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.120.e.0"/><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.120.e.2" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.120.e.0"/><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.120.e.1" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.120.e.2"/></sentence><sentence id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.121" text="A patient whose blood pressure is controlled on 25 mg of hydrochlorothiazide but is experiencing decreases in serum potassium can expect the same or incremental blood pressure effects from ATACAND HCT 16-12.5 mg and serum potassium may improve." type="negative"><entity charOffset="189:200" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.121.e.0" text="atacand hct" type="Biomedical_Entity"><Normalization><mmtx cui="C0939259" phraseText="incremental blood pressure effects from ATACAND HCT 16-12.5 mg" preferredWord="Atacand HCT" semType="phsu"/><RxNorm RxCui="215458"/></Normalization></entity><entity charOffset="116:125" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.121.e.1" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="experiencing decreases in serum potassium" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="222:231" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.121.e.2" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="serum potassium" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="48:76" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.121.e.3" text="25 mg hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0986526" phraseText="controlled on 25 mg of hydrochlorothiazide" preferredWord="Hydrochlorothiazide 25 MG" semType="clnd"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.121.e.1" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.121.e.0"/><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.121.e.0" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.121.e.2"/><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.121.e.3" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.121.e.0"/><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.121.e.3" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.121.e.1"/><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.121.e.3" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.121.e.2"/></sentence><sentence id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.122" text="A patient whose blood pressure is not controlled on 32 mg of ATACAND can expect incremental blood pressure effects from ATACAND HCT 32-12.5 mg and then 32-25 mg. " type="negative"><entity charOffset="61:68" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.122.e.0" text="atacand" type="Biomedical_Entity"><Normalization><mmtx cui="C0718711" phraseText="controlled on 32 mg of ATACAND" preferredWord="Atacand" semType="phsu, orch"/><RxNorm RxCui="215458"/></Normalization></entity><entity charOffset="120:131" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.122.e.1" text="atacand hct" type="Biomedical_Entity"><Normalization><mmtx cui="C0939259" phraseText="incremental blood pressure effects from ATACAND HCT 32-12.5 mg" preferredWord="Atacand HCT" semType="phsu"/><RxNorm RxCui="215458"/></Normalization></entity><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.122.e.0" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.122.e.1"/></sentence><sentence id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.123" text="The maximal antihypertensive effect of any dose of ATACAND HCT can be expected within 4 weeks of initiating that dose." type="negative"><entity charOffset="12:28" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.123.e.0" text="antihypertensive" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="The maximal antihypertensive effect of any dose of ATACAND HCT" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="51:62" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.123.e.1" text="atacand hct" type="Biomedical_Entity"><Normalization><mmtx cui="C0939259" phraseText="The maximal antihypertensive effect of any dose of ATACAND HCT" preferredWord="Atacand HCT" semType="phsu"/><RxNorm RxCui="215458"/></Normalization></entity><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.123.e.0" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.123.e.1"/></sentence><sentence id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.124" text="ATACAND HCT may be administered with other antihypertensive agents." type="negative"><entity charOffset="0:11" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.124.e.0" text="atacand hct" type="Biomedical_Entity"><Normalization><mmtx cui="C0939259" phraseText="ATACAND HCT" preferredWord="Atacand HCT" semType="phsu"/><RxNorm RxCui="215458"/></Normalization></entity><entity charOffset="43:66" id="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.124.e.1" text="antihypertensive agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="administered with other antihypertensive agents." preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><pair ddi="false" e1="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.124.e.0" e2="Dailymed.48b021e4-5897-42fd-12be-3190a9b087e8.s.124.e.1"/></sentence><positiveExamples number="26"/><negativeExamples number="56"/></document>